STTKShattuck Labs, Inc.
Price
+131%1YEnd-of-day closes, not the intraday tick.
A mixed picture: the questions disagree
Quality mixed, a flag to check, growth fading, the market undecided.
Charts
As reported to the SEC, without any scoring.
Shattuck Labs, Inc. (STTK) reported revenue of $0 in Q2 2026 (quarter ended Jun 30, 2026). That came with net loss of $15M. For the full year FY2025, revenue was $1.0M (−83% year on year) and net income −$49M. The next results filing is expected around Nov 5, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Jun 11, 2026Underwritten Public Offering On June 9, 2026, Shattuck Labs, Inc. (the “Company”) entered into an underwriting agreement (“Underwriting Agreement”) with Leerink Partners LLC, J.P. Morgan Securities LLC, Piper Sandler & Co. and Cantor Fitzgerald & Co., as the representatives of the underwriters named therein (the …Material agreement entered · Form 8-K
- Jun 9, 2026Data Release On June 8, 2026, the Company released its presentation on data from its Phase 1 clinical trial of SL-325.Regulation FD disclosure · Form 8-K
- Jun 2, 2026At the Annual Meeting, the Company’s stockholders approved an amendment and restatement of the Company’s 2020 Equity Incentive Plan (as so amended, the “Plan”) to revise the calculation of the automatic annual increase in the number of shares of common stock available for issuance, increase the number of shares …Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.